Long-Acting Cabotegravir/Rilpivirine Reduces Immune-Activation and -Senescence in People With HIV With CMV Co-Infection.
- DOI
- 10.1111/imm.70154
- Published
- 2026 Sep
- Container
- Immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/imm.70154,
title = {Long-Acting Cabotegravir/Rilpivirine Reduces Immune-Activation and -Senescence in People With HIV With CMV Co-Infection.},
author = {Guardiani M and Tortellini E and Carraro A and Zingaropoli MA and Ansaldo L and Grimaldi A and Vita S and Dominelli F and Mengoni F and Pasquazzi C and Turriziani O and Ciardi MR and Vullo V and Mastroianni CM and Marocco R and Borgo CD and Lichtner M},
year = {2026},
journal = {Immunology},
doi = {10.1111/imm.70154},
url = {https://doi.org/10.1111/imm.70154}
}RIS
TY - JOUR TI - Long-Acting Cabotegravir/Rilpivirine Reduces Immune-Activation and -Senescence in People With HIV With CMV Co-Infection. AU - Guardiani M AU - Tortellini E AU - Carraro A AU - Zingaropoli MA AU - Ansaldo L AU - Grimaldi A AU - Vita S AU - Dominelli F AU - Mengoni F AU - Pasquazzi C AU - Turriziani O AU - Ciardi MR AU - Vullo V AU - Mastroianni CM AU - Marocco R AU - Borgo CD AU - Lichtner M PY - 2026 JO - Immunology DO - 10.1111/imm.70154 UR - https://doi.org/10.1111/imm.70154 ER -
APA
M, G., E, T., A, C., MA, Z., L, A., A, G., S, V., F, D., F, M., C, P., O, T., MR, C., V, V., CM, M., R, M., CD, B., & M, L. (2026). Long-Acting Cabotegravir/Rilpivirine Reduces Immune-Activation and -Senescence in People With HIV With CMV Co-Infection.. Immunology. https://doi.org/10.1111/imm.70154
Source records
- pubmed · retrieved 2026-09-25T14:28:31.727Z